Won Kyu Lee (Won-Kyu Lee)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Molecular pharmaceutics

Molecules (Basel, Switzerland)

Biomedicines

Scientific reports

Osong Medical Innovation Foundation

Korea University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osong Medical Innovation Foundation Sep 23 2016

South Korea

Devision of Drug Development & Optimization/Senior Researcher :: New Drug Development Center

Korea University May 01 2015

South Korea

Research Professor :: Institute of Life Science and Natural Resources

Kookmin University Nov 01 2013

South Korea

Research Fellow :: Bio and Nano Chemistry

Kookmin University Sep 01 2010 - Aug 31 2013

South Korea

Research Professor :: Institute of Molecular Recognition and Nano Technology

Kookmin University Jul 01 2009 - Jun 30 2010

South Korea

Post Dr. :: Bio and Nano Chemistry

Korea Institute of Science and Technology Mar 01 2001 - Feb 28 2009

South Korea

KIST Academia Collaborative Education Program :: Bio-medical Research Center

Education History

Korea University Mar 01 2001 - Feb 28 2009

South Korea

PHD :: Biotechnology

Dankook University - Cheonan Campus Mar 01 1995 - Aug 31 1997

South Korea

MSC :: Biology

Dankook University - Cheonan Campus Mar 01 1991 - Feb 28 1995

South Korea

BSC :: Biology

Publications

Gyeong Min Kim, Doo Ri Park, Thi Thu Ha Nguyen, Jiseon Kim, Jihee Kim, Myung-Ho Sohn, Won Kyu Lee, Soo-Young Lee, Hyunbo Shim
Development of Anti-OSCAR Antibodies for the Treatment of Osteoarthritis. Biomedicines 11 (10) (2023)
Da Eun Hong, Ji Eun Yu, Jin Woo Lee, Dong Ju Son, Hee Pom Lee, Yuri Kim, Ju Young Chang, Dong Won Lee, Won Kyu Lee, Jaesuk Yun, Sang-Bae Han, Bang Yeon Hwang, Jin Tae Hong
A Natural CHI3L1-Targeting Compound, Ebractenoid F, Inhibits Lung Cancer Cell Growth and Migration and Induces Apoptosis by Blocking CHI3L1/AKT Signals. Molecules (Basel, Switzerland) 28 (1) (2022)
Da Eun Hong, Ji Eun Yu, Jin Woo Lee, Dong Ju Son, Hee Pom Lee, Yuri Kim, Ju Young Chang, Dong Won Lee, Won Kyu Lee, Jaesuk Yun, Sang-Bae Han, Bang Yeon Hwang, Jin Tae Hong
A Natural CHI3L1-Targeting Compound, Ebractenoid F, Inhibits Lung Cancer Cell Growth and Migration and Induces Apoptosis by Blocking CHI3L1/AKT Signals. Molecules (Basel, Switzerland) 28 (1) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Da Eun Hong, Ji Eun Yu, Jin Woo Lee, Dong Ju Son, Hee Pom Lee, Yuri Kim, Ju Young Chang, Dong Won Lee, Won Kyu Lee, Jaesuk Yun, Sang-Bae Han, Bang Yeon Hwang, Jin Tae Hong
A Natural CHI3L1-Targeting Compound, Ebractenoid F, Inhibits Lung Cancer Cell Growth and Migration and Induces Apoptosis by Blocking CHI3L1/AKT Signals. Molecules (Basel, Switzerland) 28 (1) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Jung-Hyun Na, Won Kyu Lee, Yeon Gyu Yu
How Do We Study the Dynamic Structure of Unstructured Proteins: A Case Study on Nopp140 as an Example of a Large, Intrinsically Disordered Protein. International journal of molecular sciences 19 (2) (2018)
Seong-Gu Han, Sanghwan Ko, Won Kyu Lee, Sang Taek Jung, Yeon Gyu Yu
Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directed-degeneration method. Scientific reports 7 (1) (2017)

Won Kyu Lee.css-eqlu8i{font-size:small;padding-left:4px;} (Won-Kyu Lee)

Publication Activity (10 Years)

Top Topics

Top Venues

Won Kyu Lee (Won-Kyu Lee)